Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on Equity

Aptevo Therapeutics (APVO) Debt Ratio (2016 - 2022)

Aptevo Therapeutics' Debt Ratio history spans 8 years, with the latest figure at 0.1 for Q4 2022.

  • For Q4 2022, Debt Ratio fell 62.81% year-over-year to 0.1; the TTM value through Dec 2022 reached 0.1, down 62.81%, while the annual FY2022 figure was 0.1, 62.81% down from the prior year.
  • Debt Ratio for Q4 2022 was 0.1 at Aptevo Therapeutics, down from 0.12 in the prior quarter.
  • Across five years, Debt Ratio topped out at 0.67 in Q3 2020 and bottomed at 0.1 in Q4 2022.
  • The 5-year median for Debt Ratio is 0.24 (2019), against an average of 0.26.
  • The largest annual shift saw Debt Ratio skyrocketed 106.93% in 2020 before it crashed 64.78% in 2021.
  • A 5-year view of Debt Ratio shows it stood at 0.29 in 2018, then skyrocketed by 30.21% to 0.37 in 2019, then grew by 25.81% to 0.47 in 2020, then crashed by 41.95% to 0.27 in 2021, then plummeted by 62.81% to 0.1 in 2022.
  • Per Business Quant, the three most recent readings for APVO's Debt Ratio are 0.1 (Q4 2022), 0.12 (Q3 2022), and 0.11 (Q2 2022).